Oxoplan 50mg Injection
Marketer
Samarth Life Sciences Pvt Ltd
Salt Composition
Oxaliplatin (50mg)
Overview Oxoplan 50mg Injection
Colon and rectal cancer treatment utilizes Oxoplan 50mg Injection. Its mechanism involves inhibiting or retarding cancerous cell proliferation. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician, varying based on your condition. Strict adherence to prescribed instructions is crucial; improper usage or overdose risks severe adverse effects. Therapeutic benefits may not be apparent for weeks or months; discontinue only under medical guidance. Common side effects include nausea, tiredness, vomiting, and diarrhea. Reduced blood cell counts (red and white) increase infection risk. Serious allergic reactions (sore mouth/lips, rash, itching, breathing difficulties) necessitate immediate medical attention. Regular blood tests monitor blood cell counts, along with heart, liver, and uric acid levels. Pre-treatment disclosure of heart, liver, or kidney disease, and any infection medications, is mandatory. Drug interactions are possible; inform your healthcare provider of all medications. Use during pregnancy or breastfeeding is contraindicated. Male infertility is a potential consequence; sperm preservation should be discussed with your physician. Post-injection driving is discouraged due to potential dizziness.
Uses of Oxoplan 50mg Injection
Colorectal cancer
Major Benefits of Oxoplan 50mg Injection:
Administering this medication will be handled by your healthcare provider. Please do not attempt self-medication.
Common Side effects of Oxoplan 50mg Injection:
- Nausea
- Fatigue
- Anemia (low number of red blood cells)
- Vomiting
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Low blood platelets
- Increased liver enzymes
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Stomatitis (Inflammation of the mouth)
How to use Oxoplan 50mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Oxoplan 50mg Injection works:
Oxoplan 50mg Injection is a cancer treatment that disrupts the genetic makeup (DNA and RNA) of cancerous cells, thereby inhibiting their proliferation and growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of alcohol consumption alongside Oxoplan 50mg Injection is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Oxoplan 50mg Injection during pregnancy carries a confirmed risk to the fetus and is therefore inadvisable. Nevertheless, in exceptional circumstances involving a life-threatening condition, a physician might prescribe it if the potential advantages outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Oxoplan 50mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Oxoplan 50mg Injection might induce adverse reactions impacting driving capabilities. Oxaliplatin therapy increases the likelihood of experiencing dizziness, nausea, vomiting, and other neurological effects impairing ambulation; consequently, driving may be affected.
KidneyCAUTION
For individuals with severe kidney impairment, administering Oxoplan 50mg Injection requires careful consideration and potential dosage modification. Data regarding Oxoplan 50mg Injection use in such patients is limited. Medical advice is essential. No dosage change is advised for patients exhibiting mild to moderate kidney dysfunction.
LiverCAUTION
For individuals with hepatic impairment, administration of Oxoplan 50mg Injection requires careful monitoring. Dosage modification of Oxoplan 50mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Oxoplan 50mg Injection :
Omit doses of Oxoplan 50mg Injection only after contacting your physician.
Facts to Know About Oxoplan 50mg Injection
| Label | Value |
|---|---|
| Chemical Type | Platinum Equivalents |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Platinum-based Anticancer Agents |
3,018 People bought this recently